Anti-MDA5 Antibody Spectrum in Western World
- PMID: 30382445
- DOI: 10.1007/s11926-018-0798-1
Anti-MDA5 Antibody Spectrum in Western World
Abstract
Purpose of review: Anti-melanoma differentiation-associated gene 5 (anti-MDA5) is a novel and highly specific myositis-associated autoantibody, which defines a unique phenotype among patients with dermatomyositis (DM).
Recent findings: Anti-MDA5 was originally characterized in Japan in DM patients with hallmark cutaneous features and no proximal muscle weakness and termed clinically amyopathic DM (CADM). Anti-MDA5 has characteristic cutaneous manifestations which include tender palmar papules and cutaneous ulcerations, along with an increased frequency of interstitial lung disease (ILD) that can be rapidly progressive (RPILD) and fatal. This review will highlight the clinical significance of anti-MDA5 autoantibodies in Caucasian DM patients.
Keywords: Anti-MDA5 autoantibody; Classic dermatomyositis (DM); Clinical features; Clinically amyopathic dermatomyositis (CADM).
Similar articles
-
Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.J Rheumatol. 2017 Mar;44(3):319-325. doi: 10.3899/jrheum.160682. Epub 2017 Jan 15. J Rheumatol. 2017. PMID: 28089977
-
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22. Respir Med. 2018. PMID: 29957268
-
Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.Arthritis Care Res (Hoboken). 2016 May;68(5):689-94. doi: 10.1002/acr.22728. Arthritis Care Res (Hoboken). 2016. PMID: 26414240 Free PMC article.
-
Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.Rheumatol Int. 2018 Jul;38(7):1293-1296. doi: 10.1007/s00296-018-3991-7. Epub 2018 Feb 7. Rheumatol Int. 2018. PMID: 29417209 Free PMC article. Review.
-
Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease.J Clin Lab Anal. 2022 Nov;36(11):e24726. doi: 10.1002/jcla.24726. Epub 2022 Oct 12. J Clin Lab Anal. 2022. PMID: 36221983 Free PMC article. Review.
Cited by
-
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19.medRxiv [Preprint]. 2020 Oct 15:2020.10.13.20211664. doi: 10.1101/2020.10.13.20211664. medRxiv. 2020. Update in: JCI Insight. 2022 May 9;7(9):e158362. doi: 10.1172/jci.insight.158362 PMID: 33083808 Free PMC article. Updated. Preprint.
-
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry.Rheumatol Int. 2021 Jun;41(6):1021-1036. doi: 10.1007/s00296-021-04819-1. Epub 2021 Mar 27. Rheumatol Int. 2021. PMID: 33774723 Free PMC article. Review.
-
Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies.BMC Pulm Med. 2022 Jan 10;22(1):14. doi: 10.1186/s12890-021-01802-1. BMC Pulm Med. 2022. PMID: 35000598 Free PMC article.
-
Interstitial pneumonia with autoimmune features in a patient with melanoma differentiation-associated gene 5 (MDA5) antibody.BMJ Case Rep. 2020 Nov 30;13(11):e234946. doi: 10.1136/bcr-2020-234946. BMJ Case Rep. 2020. PMID: 33257351 Free PMC article.
-
Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.J Transl Autoimmun. 2019 Aug 23;2:100013. doi: 10.1016/j.jtauto.2019.100013. eCollection 2019 Dec. J Transl Autoimmun. 2019. PMID: 32743501 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials